• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼帕病毒基质蛋白中YMYL的突变消除了出芽过程并改变了亚细胞定位。

Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization.

作者信息

Ciancanelli Michael J, Basler Christopher F

机构信息

Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA.

出版信息

J Virol. 2006 Dec;80(24):12070-8. doi: 10.1128/JVI.01743-06. Epub 2006 Sep 27.

DOI:10.1128/JVI.01743-06
PMID:17005661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1676283/
Abstract

Matrix (M) proteins reportedly direct the budding of paramyxoviruses from infected cells. In order to begin to characterize the assembly process for the highly lethal, emerging paramyxovirus Nipah virus (NiV), we have examined the budding of NiV M. We demonstrated that expression of the NiV M protein is sufficient to produce budding virus-like particles (VLPs) that are physically and morphologically similar to NiV. We identified in NiV M a sequence, YMYL, with similarity to the YPDL late domain found in the equine infectious anemia virus Gag protein. When the YMYL within NiV M was mutated, VLP release was abolished and M was relocalized to the nucleus, but the mutant M proteins retained oligomerization activity. When YMYL was fused to a late-domain mutant of the Ebola virus VP40 matrix protein, VP40 budding was restored. These results suggest that the YMYL sequence may act as a trafficking signal and a late domain for NiV M.

摘要

据报道,基质(M)蛋白指导副粘病毒从受感染细胞中出芽。为了开始表征高致死性新兴副粘病毒尼帕病毒(NiV)的组装过程,我们研究了NiV M的出芽情况。我们证明,NiV M蛋白的表达足以产生在物理和形态上与NiV相似的出芽病毒样颗粒(VLP)。我们在NiV M中鉴定出一个序列YMYL,它与马传染性贫血病毒Gag蛋白中的YPDL晚期结构域相似。当NiV M中的YMYL发生突变时,VLP释放被消除,M重新定位到细胞核,但突变的M蛋白保留了寡聚化活性。当YMYL与埃博拉病毒VP40基质蛋白的晚期结构域突变体融合时,VP40出芽得以恢复。这些结果表明,YMYL序列可能作为NiV M的转运信号和晚期结构域。

相似文献

1
Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization.尼帕病毒基质蛋白中YMYL的突变消除了出芽过程并改变了亚细胞定位。
J Virol. 2006 Dec;80(24):12070-8. doi: 10.1128/JVI.01743-06. Epub 2006 Sep 27.
2
The YPLGVG sequence of the Nipah virus matrix protein is required for budding.尼帕病毒基质蛋白的YPLGVG序列是出芽所必需的。
Virol J. 2008 Nov 10;5:137. doi: 10.1186/1743-422X-5-137.
3
Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.泛素调控的尼帕病毒基质蛋白的核质转运对病毒出芽是重要的。
PLoS Pathog. 2010 Nov 11;6(11):e1001186. doi: 10.1371/journal.ppat.1001186.
4
Cytoplasmic Motifs in the Nipah Virus Fusion Protein Modulate Virus Particle Assembly and Egress.尼帕病毒融合蛋白中的细胞质基序调节病毒粒子的组装和释放。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02150-16. Print 2017 May 15.
5
Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability.尼帕病毒基质蛋白影响融合性,对病毒颗粒的感染性和稳定性至关重要。
J Virol. 2015 Dec 16;90(5):2514-22. doi: 10.1128/JVI.02920-15.
6
C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles.副粘病毒核衣壳蛋白中含C末端DxD的序列决定基质蛋白兼容性,并可将外源蛋白导向出芽颗粒。
J Virol. 2016 Jan 20;90(7):3650-60. doi: 10.1128/JVI.02673-15.
7
Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein.对作为病毒样颗粒释放的尼帕病毒蛋白进行定量分析,揭示了基质蛋白的核心作用。
Virol J. 2007 Jan 4;4:1. doi: 10.1186/1743-422X-4-1.
8
Nipah virus matrix protein: expert hacker of cellular machines.尼帕病毒基质蛋白:细胞机器的专业“黑客”
FEBS Lett. 2016 Aug;590(15):2494-511. doi: 10.1002/1873-3468.12272. Epub 2016 Jul 12.
9
ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.ALIX拯救埃博拉病毒VP40双PTAP/PPEY L结构域缺失突变体的出芽:ALIX在埃博拉病毒释放中的作用
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S138-45. doi: 10.1093/infdis/jiu838. Epub 2015 Mar 18.
10
A leucine residue in the C terminus of human parainfluenza virus type 3 matrix protein is essential for efficient virus-like particle and virion release.人副流感病毒3型基质蛋白C末端的一个亮氨酸残基对于高效释放病毒样颗粒和病毒体至关重要。
J Virol. 2014 Nov;88(22):13173-88. doi: 10.1128/JVI.01485-14. Epub 2014 Sep 3.

引用本文的文献

1
Antigenic and mutational insights into the Nipah virus G glycoprotein: implications for viral entry, host specificity, therapeutics, and vaccine development.尼帕病毒G糖蛋白的抗原性和突变研究:对病毒进入、宿主特异性、治疗方法及疫苗开发的启示
PeerJ. 2025 Aug 12;13:e19835. doi: 10.7717/peerj.19835. eCollection 2025.
2
Identification of conserved CD8+ T cell epitopes in Nipah virus towards vaccine development using an immunoinformatics approach.利用免疫信息学方法鉴定尼帕病毒中保守的CD8+ T细胞表位以用于疫苗开发
Clin Exp Vaccine Res. 2025 Jul;14(3):229-245. doi: 10.7774/cevr.2025.14.e22. Epub 2025 Apr 14.
3
Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes.设计一种基于细胞微小RNA的方法来沉默蝙蝠传播的尼帕病毒基因。
J Neurovirol. 2025 Jul 7. doi: 10.1007/s13365-025-01268-5.
4
Ephrin B1 and B2 Mediate Cedar Virus Entry into Egyptian Fruit Bat Cells.Ephrin B1和B2介导雪松病毒进入埃及果蝠细胞。
Viruses. 2025 Apr 16;17(4):573. doi: 10.3390/v17040573.
5
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics.亨尼帕病毒:流行病学、生态学、疾病以及疫苗和治疗方法的发展
Clin Microbiol Rev. 2025 Mar 13;38(1):e0012823. doi: 10.1128/cmr.00128-23. Epub 2024 Dec 23.
6
Recent Advances of Nipah Virus Disease: Pathobiology to Treatment and Vaccine Advancement.尼帕病毒病的最新进展:从发病机制到治疗和疫苗进展。
J Microbiol. 2024 Oct;62(10):811-828. doi: 10.1007/s12275-024-00168-3. Epub 2024 Sep 18.
7
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
8
Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.呼吸道合胞病毒基质蛋白晶格的组装及其与融合糖蛋白三聚体的协调。
Nat Commun. 2024 Jul 14;15(1):5923. doi: 10.1038/s41467-024-50162-x.
9
Virus-like particles (VLPs): A promising platform for combating against Newcastle disease virus.病毒样颗粒(VLPs):对抗新城疫病毒的一个有前景的平台。
Vaccine X. 2024 Jan 14;16:100440. doi: 10.1016/j.jvacx.2024.100440. eCollection 2024 Jan.
10
Novel "GaEl Antigenic Patches" Identified by a "Reverse Epitomics" Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human Health.通过“反向表位组学”方法鉴定出新型“GaEl抗原表位”,用于设计针对尼帕病毒感染的多表位疫苗,尼帕病毒感染是对全球人类健康的潜在威胁。
ACS Omega. 2023 Aug 22;8(35):31698-31713. doi: 10.1021/acsomega.3c01909. eCollection 2023 Sep 5.

本文引用的文献

1
Feral cats and risk for Nipah virus transmission.流浪猫与尼帕病毒传播风险
Emerg Infect Dis. 2006 Jul;12(7):1178-9. doi: 10.3201/eid1207.050799.
2
N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.尼帕病毒融合蛋白上的N-聚糖可防止病毒被中和,但会降低膜融合和病毒进入能力。
J Virol. 2006 May;80(10):4878-89. doi: 10.1128/JVI.80.10.4878-4889.2006.
3
Nipah virus-associated encephalitis outbreak, Siliguri, India.印度西里古里尼帕病毒相关脑炎疫情
Emerg Infect Dis. 2006 Feb;12(2):235-40. doi: 10.3201/eid1202.051247.
4
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus.埃菲林B3中的两个关键残基对其作为尼帕病毒的替代受体的用途至关重要。
PLoS Pathog. 2006 Feb;2(2):e7. doi: 10.1371/journal.ppat.0020007. Epub 2006 Feb 10.
5
A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L.尼帕病毒融合蛋白的成熟且具有融合活性的形式需要组织蛋白酶L进行蛋白水解加工。
Virology. 2006 Mar 15;346(2):251-7. doi: 10.1016/j.virol.2006.01.007. Epub 2006 Feb 7.
6
Genetic characterization of Nipah virus, Bangladesh, 2004.2004年孟加拉国尼帕病毒的基因特征分析
Emerg Infect Dis. 2005 Oct;11(10):1594-7. doi: 10.3201/eid1110.050513.
7
Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein.内吞作用在亨德拉病毒融合蛋白的蛋白水解加工过程中起关键作用。
J Virol. 2005 Oct;79(20):12643-9. doi: 10.1128/JVI.79.20.12643-12649.2005.
8
Ebola virus VP40 late domains are not essential for viral replication in cell culture.埃博拉病毒VP40晚期结构域对于病毒在细胞培养中的复制并非必不可少。
J Virol. 2005 Aug;79(16):10300-7. doi: 10.1128/JVI.79.16.10300-10307.2005.
9
Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.尼帕病毒融合糖蛋白的七肽衍生肽对亨尼帕病毒融合和感染的抑制作用。
Virol J. 2005 Jul 18;2:57. doi: 10.1186/1743-422X-2-57.
10
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus.埃菲林B2是尼帕病毒(一种新出现的致命副粘病毒)的进入受体。
Nature. 2005 Jul 21;436(7049):401-5. doi: 10.1038/nature03838. Epub 2005 Jul 6.